What healthcare?
The US spends roughly twice what peer countries spend per person on healthcare and gets a lower life expectancy. The gap is not quality, it's price. Every major line item (drugs, hospital procedures, administrative overhead) costs multiples of what the same service costs in Germany, France, Canada, or Japan.
$13,493 per capita here vs $6,469 across 14 peer countries.
US: 78.4 years. Peer average: 82.4. Japan, the best, reaches 84.
~$220B total. 530K households file medical bankruptcy annually. 48% of US adults delayed or skipped care due to cost in 2024.
Healthcare's share of US GDP
In 1960, healthcare was 5% of US GDP. By 2023 it was 17.6%. No peer country has followed the same trajectory. Germany and Switzerland plateaued near 12%; the UK at 10%.
US health spending as % of GDP
CMS National Health Expenditure Accounts
Per-capita spending vs life expectancy
Every peer country spends less and lives longer. The US line below is nearly 2× the next-highest spender (Switzerland) and gets 5 fewer years of life at the median.
Where the same coverage costs less
Enter your gross household income. The table shows annual healthcare contribution under the US employer-sponsored model (KFF 2024 average family premium + mean out-of-pocket) versus what you'd pay under peer-country systems. US figures are largely flat in dollars across incomes, which is why they're regressive as a % of income.
| System | Annual cost | % of income | vs US |
|---|---|---|---|
United States See below, flat-dollar model, not income-indexed | $7.8K | 9.8% | |
Germany Statutory health insurance employee share | $5.8K | 7.3% | −$2.0K |
France Effective household contribution (mostly employer payroll) | $5.2K | 6.5% | −$2.6K |
UK (NHS) Funded from general taxation | $3.6K | 4.5% | −$4.2K |
Canada Federal + provincial health taxes | $4.4K | 5.5% | −$3.4K |
Japan Employee share of statutory insurance | $4.0K | 5.0% | −$3.8K |
Australia Medicare levy + general tax | $1.6K | 2.0% | −$6.2K |
Economic incidence. The employer share of US premiums (~$17.7K for a family plan) is not free money, it's wage suppression. Academic consensus (Summers 1989, Gruber 2000) is that 70-100% of employer premiums are borne by workers through lower wages. Including the employer share would roughly triple the US line above.
Coverage isn't identical. Peer systems cover nearly everyone with no deductible and capped copays. US employer plans have $1,800 average deductibles (family OOP max ~$18K). Single-payer eliminates ~$15K of catastrophic risk the US worker still carries.
Prescription prices: US vs OECD
RAND's 2024 report on US vs peer drug prices: list prices average 4.22× peer-country list prices for brand-name drugs. Specific blockbusters below. Insurance blunts the sticker but it still flows into premiums.
| Drug | US | OECD avg | Multiple |
|---|---|---|---|
Ozempic (semaglutide) Type 2 diabetes / weight loss | $969 | $155 | 6.3× |
Eliquis (apixaban) Blood thinner | $594 | $116 | 5.1× |
Humira (adalimumab) Autoimmune | $7,389 | $1,250 | 5.9× |
Keytruda (pembrolizumab) Cancer immunotherapy | $12,423 | $3,640 | 3.4× |
Revlimid (lenalidomide) Multiple myeloma | $24,000 | $4,500 | 5.3× |
Insulin glargine (Lantus) Diabetes | $335 | $47 | 7.1× |
EpiPen Anaphylaxis (auto-injector) | $650 | $110 | 5.9× |
Xarelto (rivaroxaban) Blood thinner | $555 | $102 | 5.4× |
Why US drug prices are higher. Medicare was legally barred from negotiating drug prices until the 2022 Inflation Reduction Act, which opened negotiation on a short list of 10 drugs starting in 2026. Peer countries negotiate nationally and reference-price off each other, creating downward pressure the US market lacks. Branded-drug patent periods are also strategically extended (evergreening, authorized generics) in ways that are harder elsewhere.
Where a healthcare dollar goes
Commonwealth Fund / CMS breakdown of US total health spending. Administrative overhead (billing, coding, insurance admin) is the single line that stands out vs peer countries.
Administrative overhead, by system
The single largest line item where the US diverges from peer countries. Medicare (US public) runs at ~2% overhead, comparable to UK NHS and Canada. US private insurance runs at 17%. Hospital billing and insurance-interface admin pushes the delivery side to 25%. That is where an estimated $400-600B of the US "healthcare" cost lives.
What ordinary people can actually do
Max out your HSA if you can
The Health Savings Account is the only triple-tax-advantaged account in US tax law: pre-tax in, tax-free growth, tax-free withdrawal for medical. After age 65 it functions like an IRA for non-medical spending. Requires an HDHP. See the tax-advantaged accounts section of /investing.
Always ask for the cash price
For imaging, prescriptions, and many outpatient procedures, the cash-pay price is often 30-70% below what insurance is billed. GoodRx, Cost Plus Drugs, and state price transparency laws give you the numbers. Hospitals are legally required to publish chargemasters; compare.
Negotiate every bill
Hospitals routinely accept 30-60% of a bill on a phone call, especially if you ask for financial-hardship review or a cash-discount. Medical debt under $500 no longer affects credit reports (2023 CFPB rule). Don't pay the first invoice without asking for itemization.
Use in-network urgent care, not ERs
The median US ER visit is billed at ~$2,400 before insurance. The same care at an urgent-care clinic is $150-400. Save ERs for chest pain, stroke symptoms, serious injuries. For anything else, urgent care / telehealth is the move.
Not a clinical or legal reference. This page is about the structural economics of US healthcare. Your individual plan, state, and employer determine the specifics. For plan shopping, use healthcare.gov or your state marketplace. For prescription pricing, compare GoodRx and Cost Plus Drugs on every refill, they're often cheaper than your insurance copay.